Literature DB >> 33107689

Is there a role for botanical medicines in the twenty-first century?: Promotion of untested traditional therapies by the World Health Organization and China endangers global public health.

Arthur P Grollman1, Donald M Marcus2.   

Abstract

China and the WHO's promotion of herbal and traditional medicines, most of which were not tested for safety and efficacy, have raised public health concerns.
© 2020 The Authors.

Mesh：

Year:  2020        PMID： 33107689      PMCID： PMC7645263          DOI： 10.15252/embr.202051376

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


  15 in total

1.  Aristolochic acids.

Authors: 
Journal:  Rep Carcinog       Date:  2011

2.  The World Health Organization's decision about traditional Chinese medicine could backfire.

Authors: 
Journal:  Nature       Date:  2019-06       Impact factor: 49.962

3.  WHO's Next - The United States and the World Health Organization.

Authors:  Barry R Bloom; Paul E Farmer; Eric J Rubin
Journal:  N Engl J Med       Date:  2020-07-15       Impact factor: 91.245

4.  Why Chinese medicine is heading for clinics around the world.

Authors:  David Cyranoski
Journal:  Nature       Date:  2018-09       Impact factor: 49.962

Review 5.  Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations.

Authors:  R Teschke; A Wolff; C Frenzel; J Schulze
Journal:  Aliment Pharmacol Ther       Date:  2014-05-20       Impact factor: 8.171

6.  Global hazards of herbal remedies: lessons from Aristolochia: The lesson from the health hazards of Aristolochia should lead to more research into the safety and efficacy of medicinal plants.

Authors:  Arthur P Grollman; Donald M Marcus
Journal:  EMBO Rep       Date:  2016-04-25       Impact factor: 8.807

7.  Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.

Authors:  Alvin W T Ng; Song Ling Poon; Mi Ni Huang; Jing Quan Lim; Arnoud Boot; Willie Yu; Yuka Suzuki; Saranya Thangaraju; Cedric C Y Ng; Patrick Tan; See-Tong Pang; Hao-Yi Huang; Ming-Chin Yu; Po-Huang Lee; Sen-Yung Hsieh; Alex Y Chang; Bin T Teh; Steven G Rozen
Journal:  Sci Transl Med       Date:  2017-10-18       Impact factor: 17.956

8.  Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Authors:  J L Nortier; M C Martinez; H H Schmeiser; V M Arlt; C A Bieler; M Petein; M F Depierreux; L De Pauw; D Abramowicz; P Vereerstraeten; J L Vanherweghem
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

Review 9.  Safety surveillance of traditional Chinese medicine: current and future.

Authors:  Shwu-Huey Liu; Wu-Chang Chuang; Wing Lam; Zaoli Jiang; Yung-Chi Cheng
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 10.  Acute kidney injury associated with the use of traditional medicines.

Authors:  Valerie A Luyckx; Saraladevi Naicker
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-07
View more
  3 in total

1.  Is there a role for botanical medicines in the twenty-first century?: Promotion of untested traditional therapies by the World Health Organization and China endangers global public health.

Authors:  Arthur P Grollman; Donald M Marcus
Journal:  EMBO Rep       Date:  2020-10-27       Impact factor: 8.807

2.  The Effect of Chinese Medicinal Formulas on Biomarkers of Oxidative Stress in STZ-Induced Diabetic Kidney Disease Rats: A Meta-Analysis and Systematic Review.

Authors:  Qian Zhou; Chuyi Han; Yanmei Wang; Shunlian Fu; Yiding Chen; Qiu Chen
Journal:  Front Med (Lausanne)       Date:  2022-04-15

Review 3.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.